Minya Pu
Overview
Explore the profile of Minya Pu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
72
Citations
2245
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Belsuzarri M, Sako Y, Brown T, Chan M, Cozza R, Jin J, et al.
J Med Chem
. 2024 Aug;
67(16):13703-13722.
PMID: 39115891
Extracellular vesicles (EVs) can transfer antigens and immunomodulatory molecules, and such EVs released by antigen-presenting cells equipped with immunostimulatory functions have been utilized for vaccine formulations. A prior high-throughput screening...
2.
Shatsky R, Batra-Sharma H, Helsten T, Schwab R, Pittman E, Pu M, et al.
Breast Cancer Res
. 2024 Mar;
26(1):46.
PMID: 38481291
No abstract available.
3.
Shatsky R, Batra-Sharma H, Helsten T, Schwab R, Pittman E, Pu M, et al.
Breast Cancer Res
. 2024 Feb;
26(1):32.
PMID: 38408999
Background: Zilovertamab is a humanized monoclonal antibody targeting ROR1, an onco-embryonic antigen expressed by malignant cells of a variety of solid tumors, including breast cancer. A prior phase 1 study...
4.
Gulay K, Zhang X, Pantazopoulou V, Patel J, Esparza E, Sheik Pran Babu D, et al.
Cancer Res
. 2023 Jun;
83(18):3001-3012.
PMID: 37378556
Significance: KRAS-mutant pancreatic cancer models, including KRAS inhibitor-resistant models, show exquisite sensitivity to combined pan-ERBB and KRAS targeting, which provides the rationale for testing this drug combination in clinical trials.
5.
Sako Y, Sato-Kaneko F, Shukla N, Yao S, Belsuzarri M, Chan M, et al.
ACS Chem Biol
. 2023 Apr;
18(4):982-993.
PMID: 37039433
Extracellular vesicles (EVs) transfer antigens and immunomodulatory molecules in immunologic synapses as a part of intracellular communication, and EVs equipped with immunostimulatory functions have been utilized for vaccine formulation. Hence,...
6.
Kwan B, Fuhrer T, Montemayor D, Fink J, He J, Hsu C, et al.
BMC Bioinformatics
. 2023 Feb;
24(1):57.
PMID: 36803209
Background: The growing amount of high dimensional biomolecular data has spawned new statistical and computational models for risk prediction and disease classification. Yet, many of these methods do not yield...
7.
Shankara Narayanan J, Hayashi T, Erdem S, McArdle S, Tiriac H, Ray P, et al.
J Immunother Cancer
. 2023 Jan;
11(1).
PMID: 36634919
Background: Pancreatic cancer (PC) has a poor prognosis, and most patients present with either locally advanced or distant metastatic disease. Irreversible electroporation (IRE) is a non-thermal method of ablation used...
8.
Shukla N, Sato-Kaneko F, Yao S, Pu M, Chan M, Lao F, et al.
Front Pharmacol
. 2022 Apr;
13:869649.
PMID: 35479316
Extracellular vesicles (EVs) play an important role in intercellular communication and regulation of cells, especially in the immune system where EVs can participate in antigen presentation and may have adjuvant...
9.
Saito T, Shukla N, Sato-Kaneko F, Sako Y, Hosoya T, Yao S, et al.
ACS Chem Biol
. 2022 Jan;
17(1):217-229.
PMID: 34985883
There remains an unmet need for reliable fully synthetic adjuvants that increase lasting protective immune responses from vaccines. We previously reported a high-throughput screening for small molecules that extended nuclear...
10.
Saito R, Hirayama A, Akiba A, Kamei Y, Kato Y, Ikeda S, et al.
Metabolites
. 2021 Oct;
11(10).
PMID: 34677386
Acute kidney injury (AKI) is defined as a rapid decline in kidney function. The associated syndromes may lead to increased morbidity and mortality, but its early detection remains difficult. Using...